Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII).
about
Profile of brivaracetam and its potential in the treatment of epilepsyMonoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target DrugsThirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional AnalysisUpdate on the treatment of narcolepsy: clinical efficacy of pitolisantEmerging strategies in the management of essential tremor.Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome(1,2,3).Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice.Anticonvulsant and Toxicological Evaluation of Parafluorinated/Chlorinated Derivatives of 3-Hydroxy-3-ethyl-3-phenylpropionamide.Cannabinoids: is there a potential treatment role in epilepsy?2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side EffectsHuperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice.The potential role of cannabinoids in epilepsy treatment.The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.Evaluation of brivaracetam: a new drug to treat epilepsy.Brivaracetam for the treatment of epilepsy.Mood stabilizers inhibit cytomegalovirus infection.Exploring the latest avenues for antiepileptic drug discovery and development.Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research.Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).Altered gene expression profile in a mouse model of SCN8A encephalopathy.An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.Self-administration of progesterone and synthetic neuroactive steroids by male rhesus monkeys.Proconvulsant effects of the ketogenic diet in electroshock-induced seizures in mice.Brexanolone as adjunctive therapy in super-refractory status epilepticus.Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts.Development and pharmacologic characterization of the rat 6 Hz model of partial seizures.Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.In vitro and in vivo evaluation of silk fibroin functionalized with GABA and allopregnanolone for Schwann cell and neuron survival.A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop?Synthesis and Determination of Lipophilicity, Anticonvulsant Activity, and Preliminary Safety of 3-Substituted and 3-Unsubstituted N-[(4-Arylpiperazin-1-yl)alkyl]pyrrolidine-2,5-dione Derivatives.Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy.Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.Alterations in the Timing of Huperzine A Cerebral Pharmacodynamics in the Acute Traumatic Brain Injury Setting.Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.Contraception for women with epilepsy: counseling, choices, and concerns.Antiepileptic drugs in development pipeline: A recent update.
P2860
Q26776317-685F5541-740D-441F-9180-31C6E1FA466FQ28074736-8E843FC0-D93A-47C6-93B5-A661A26D9B48Q28553714-304D0F8B-46A6-492E-B2A4-0F5F33D8C3E1Q33631290-F75054CC-3074-4B35-8961-890292216400Q34554826-277662A1-4AA9-41AE-AC51-6B22255ADAC8Q35805872-DFBD987B-CCE7-44CB-B98D-C0A54F71F33FQ36244649-0C5342EF-6C58-441B-9BB1-CF035BCABFBAQ36666003-300B8FEE-A497-4A6C-885C-0134C80C4595Q36837343-277D35EE-ADF1-479C-A510-E77E1DC90EC7Q37021062-74531C59-56EF-4023-B1D4-9C2F4C360D2CQ37342533-2E87AB6C-FCEB-4121-8A58-ECC041F2D61BQ38606080-5306BBF4-08BB-4BB1-8C7C-3C6B70C711C9Q38614499-AF9A3FEE-1254-4A7E-A714-A178965EC254Q38626838-A8B3AD0A-6677-4EB3-88CF-08E76B422198Q38652806-E3AFE5C5-3EAF-4CB2-A857-F36EE5A8C820Q38694479-77F9DB20-77D7-4540-9A57-85F044C61FF5Q38744376-E06C3EF0-23A5-4E6C-BF02-B98ABB3F5BDBQ38754189-71870E3E-41C2-4BF5-9083-7373AF478C63Q38810282-8109D3C2-4117-46BB-923B-D7844D9158BCQ39006241-E8E23564-1B12-491A-902A-37C09F6F6490Q39194220-CEB9E967-A315-421F-9663-650D72AA5C5EQ39431492-67FBDB36-F4C1-47AD-924B-3B7422F45722Q41669344-B963B42A-6D57-42D4-B3CE-7F53565D3F33Q41884732-8047A27F-23BD-41DE-92F9-C415ABFDD180Q42317046-FAE727B5-BD45-40C1-91E3-EE8B39C09744Q42702432-F5B6840E-8173-43EF-B1E6-6E4F79A9FD42Q44921188-2C9F4015-BD0B-4167-B0CF-5F3138D66C20Q46375658-DD9287D5-31E1-4BAD-8865-E70CE2C7BCCFQ47139898-0690C6B2-7E42-4BAC-A5CE-1523E104E1F5Q47328168-6A7883BA-5A87-4F8A-9AEB-60AC613B711FQ47548600-EB94377E-C225-49EA-A6E7-CABF50AA5D36Q47633070-18EF97CB-ECE8-450B-B35B-1AE2A4AD35CDQ47643955-78CBA3F4-09DB-43D5-83AD-219B6AAA22C8Q47696307-56924DB9-9610-4CEF-8D06-D4A40A5D8923Q47732819-C4ACAD75-54C9-4AFF-B0F2-64BBC3C39E15Q47967839-980D2254-7FC2-40F2-A9E5-6B4FD2CA5707Q48009440-4D76609D-EC6C-435E-BE3C-3EC93F4372E1Q48352136-7432C82B-834F-4D12-A317-58F52DFDC87DQ49540132-7CC96E22-DE64-4190-BE79-130A3DAF8039Q49882750-61F6DECC-FFBC-440E-BA69-BFDE59FF1D8F
P2860
Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Progress report on new antiepi ...... Eilat Conference (EILAT XII).
@en
type
label
Progress report on new antiepi ...... Eilat Conference (EILAT XII).
@en
prefLabel
Progress report on new antiepi ...... Eilat Conference (EILAT XII).
@en
P2093
P1433
P1476
Progress report on new antiepi ...... Eilat Conference (EILAT XII).
@en
P2093
H Steve White
Meir Bialer
René H Levy
Svein I Johannessen
P304
P356
10.1016/J.EPLEPSYRES.2015.01.001
P577
2015-01-19T00:00:00Z